Products
Leading Manufacturer for Use Of Trypsin Enzyme - Kallidinogenase of Deebio for Variety of Cardiovascular and Cerebovascular Disease – Deebiotech
Leading Manufacturer for Use Of Trypsin Enzyme - Kallidinogenase of Deebio for Variety of Cardiovascular and Cerebovascular Disease – Deebiotech Detail:
Detail
1. Characters: White or almost white powder, odourless.
2. Extraction Source: Porcine pancreas.
3. Process: Kallidinogenase is extracted from healthy porcine pancreas.
4. Indications and uses:This product can be used for a variety of cardiovascular and cerebovascular disease, such as coronary heart disease, cerebral arteriosclerosis, cerebral thrombosis, retinal blood supply disorders and peripheral vascular disease. Have a better therapeutic effect on recent researches for thr prevention of early diabetic microangiopathy and diabetic nephropathy, can reduce the albumin excretion. Clinical data both at home and abroad suggest that it can increase sperm activity and production quantity, and has certain curative effect in the treatment of some male sterility.
Why us？
·Produced in GMP workshop
·27 years of biological enzyme R&D history
·Raw materials are traceable
·Comply with customer standard
·Export to over 30 countries and regions
·Has the ability of quality system management such as US FDA, Japan PMDA, South Korea MFDS, etc.
Specification
|
Test Items |
Company Specification |
||
|
CP |
JP |
||
|
Characters |
White or almost white powder, odourless |
White to slighty brown powder, odourless or has a faint |
|
|
Identification |
R (hydrolysis rate): 0.12～0.17 |
R (hydrolysis rate): 0.12～0.16 |
|
|
Liquid Chromatography: Conforms |
I : ≤ 0.2 |
||
|
Tests |
pH |
5.5～7.5（300unit/ml） |
5.5～7.5（1g/300ml） |
|
Clarity of solution |
Clear（2mg/ml） |
———— |
|
|
Fat |
≤ 5.0mg/g |
≤ 1.0mg/g |
|
|
Kininase |
———— |
R Value：≥ 0.8 |
|
|
Trypsin-like substance |
———— |
T Value：≤ 0.05 |
|
|
Protease |
A280 ≤ 0.2 |
A280 ≤ 0.2 |
|
|
Loss on drying |
≤ 5.0% (60℃ Dry in Vacuum, 4h) |
≤ 2.0% (60℃ Dry in Vacuum, 4h) |
|
|
Residue on ignition |
≤ 3.0% |
≤ 3.0% |
|
|
Kinin-releasing activity |
———— |
≥ 500ng bradykinin equivalent/min/unit per unit |
|
|
Purity |
≥ 75% (for oral) |
———— |
|
|
≥ 90% (for injection) |
|||
|
Bacterial endotoxin |
≤ 2.5 EU/unit (for injection) |
———— |
|
|
Assay |
Enzyme activity |
———— |
≥ 25 unit/mg |
|
Specific activity |
≥ 300 unit/mg protein (for oral) |
≥ 100 unit/mg protein |
|
|
≥ 600 unit/mg protein (for injection) |
|||
|
Microbial Impurities |
TAMC |
≤ 1000cfu/g (for oral) |
≤ 1000cfu/g |
|
≤ 100cfu/g (for injection) |
|||
|
TYMC |
≤ 100cfu/g |
≤ 100cfu/g |
|
|
E.coli |
Conforms |
Conforms |
|
|
Salmonella |
Conforms |
Conforms |
|
Product detail pictures:
Related Product Guide:
Together with the "Client-Oriented" enterprise philosophy, a arduous good quality control technique, sophisticated producing equipment and a sturdy R&D staff, we generally offer superior quality merchandise, superb solutions and aggressive rates for Leading Manufacturer for Use Of Trypsin Enzyme - Kallidinogenase of Deebio for Variety of Cardiovascular and Cerebovascular Disease – Deebiotech , The product will supply to all over the world, such as: Cannes, US, Karachi, With a team of experienced and knowledgeable personnel, our market covers South America, the USA, the Mid East, and North Africa. Many customers have become our friends after good cooperation with us. If you have the requirement for any of our products, please contact us now. We are looking forward to hearing from you soon.
By Anna from Algeria - 2017.02.18 15:54
The company can keep up with the changes in this industry market, product updates fast and the price is cheap, this is our second cooperation, it's good.
By Dee Lopez from Hyderabad - 2018.12.05 13:53
